Association of single nucleotide polymorphisms in the genes ATM, GSTP1, SOD2, TGFB1, XPD and XRCC1 with risk of severe erythema after breast conserving radiotherapy
Open Access
- 26 April 2012
- journal article
- Published by Springer Science and Business Media LLC in Radiation Oncology
- Vol. 7 (1), 65
- https://doi.org/10.1186/1748-717X-7-65
Abstract
To examine the association of polymorphisms in ATM (codon 158), GSTP1 (codon 105), SOD2 (codon 16), TGFB1 (position -509), XPD (codon 751), and XRCC1 (codon 399) with the risk of severe erythema after breast conserving radiotherapy. Retrospective analysis of 83 breast cancer patients treated with breast conserving radiotherapy. A total dose of 50.4 Gy was administered, applying 1.8 Gy/fraction within 42 days. Erythema was evaluated according to the Radiation Therapy Oncology Group (RTOG) score. DNA was extracted from blood samples and polymorphisms were determined using either the Polymerase Chain Reaction based Restriction-Fragment-Length-Polymorphism (PCR-RFL) technique or Matrix-Assisted-Laser-Desorption/Ionization -Time-Of-Flight-Mass-Spectrometry (MALDI-TOF). Relative excess heterozygosity (REH) was investigated to check compatibility of genotype frequencies with Hardy-Weinberg equilibrium (HWE). In addition, p-values from the standard exact HWE lack of fit test were calculated using 100,000 permutations. HWE analyses were performed using R. Fifty-six percent (46/83) of all patients developed erythema of grade 2 or 3, with this risk being higher for patients with large breast volume (odds ratio, OR = 2.55, 95% confidence interval, CI: 1.03-6.31, p = 0.041). No significant association between SNPs and risk of erythema was found when all patients were considered. However, in patients with small breast volume the TGFB1 SNP was associated with erythema (p = 0.028), whereas the SNP in XPD showed an association in patients with large breast volume (p = 0.046). A risk score based on all risk alleles was neither significant in all patients nor in patients with small or large breast volume. Risk alleles of most SNPs were different compared to a previously identified risk profile for fibrosis. The genetic risk profile for erythema appears to be different for patients with small and larger breast volume. This risk profile seems to be specific for erythema as compared to a risk profile for fibrosis.Keywords
This publication has 54 references indexed in Scilit:
- No association between SNPs regulating TGF-β1 secretion and late radiotherapy toxicity to the breast: Results from the RAPPER studyRadiotherapy and Oncology, 2010
- Biomarkers and Surrogate Endpoints for Normal-Tissue Effects of Radiation Therapy: The Importance of Dose–Volume EffectsInternational Journal of Radiation Oncology*Biology*Physics, 2010
- Genetic polymorphisms in DNA repair and damage response genes and late normal tissue complications of radiotherapy for breast cancerBritish Journal of Cancer, 2009
- Radiotherapy for the management of locally advanced squamous cell carcinoma of the head and neckOral Diseases, 2009
- Association of Single Nucleotide Polymorphisms inSOD2, XRCC1andXRCC3with Susceptibility for the Development of Adverse Effects Resulting from Radiotherapy for Prostate CancerRadiation Research, 2008
- The late radiotherapy normal tissue injury phenotypes of telangiectasia, fibrosis and atrophy in breast cancer patients have distinct genotype-dependent causesBritish Journal of Cancer, 2007
- Global variation in copy number in the human genomeNature, 2006
- A single nucleotide polymorphism based approach for the identification and characterization of gene expression modulation using MassARRAYMutation research. Reviews in mutation research, 2005
- Association of transforming growth factor beta-1 single nucleotide polymorphisms with radiation-induced damage to normal tissues in breast cancer patientsInternational Journal of Radiation Biology, 2003
- Prognostic factors for acute and late skin reactions in radiotheraphy patientsInternational Journal of Radiation Oncology*Biology*Physics, 1996